Evidence map›Paper›PMID 28621653›Full record

ArticleCanadian journal of public health = Revue canadienne de sante publique2017

Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in Canada.

Anita C Benoit, Jaime Younger, Kerrigan Beaver, Randy Jackson, Mona Loutfy, Renée Masching, Tony Nobis, Earl Nowgesic, Doe O'Brien-Teengs, Wanda Whitebird and 14 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Canadian journal of public health = Revue canadienne de sante publique, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. An allied research paradigm for epidemiology research with Indigenous peoples.Archives of public health = Archives belges de sante publique · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 11 institutions in 4 countries.

Anita C BenoitWomen's College Research Institute, Women's College Hospital, Toronto, ON; Building Bridges Team, Toronto, ON and/or Vancouver, BC. anita.benoit@wchospital.ca.
Jaime Younger
Kerrigan Beaver
Randy Jackson
Mona Loutfy
Renée Masching
Tony Nobis
Earl Nowgesic
Doe O'Brien-Teengs
Wanda Whitebird
Art Zoccole
Mark Hull
Denise Jaworsky
Elizabeth Benson
Anita Rachlis
Sean B Rourke
Ann N Burchell
Curtis Cooper
Robert S Hogg
Marina B Klein
Nima Machouf
Julio S G Montaner
Chris Tsoukas
Janet Raboud
University of British Columbia · CAUniversity of Toronto · CASt. Michael's Hospital · CAUniversity Health Network · CABuilding Bridges · USSimon Fraser University · CAAssembly of First Nations · CALakehead University · CAMcGill University Health Centre · CASunnybrook Health Science Centre · CAWomen's College Hospital · CA

Funding

Seek and Treat for Optimal Prevention of HIV & AIDS (STOP HIV/AIDS) in BCR01DA036307 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MONTANER, JULIO SERGIO GONZALEZ · 2013 to 2017
$3.0M
NIDA NIH HHS R01 DA036307
6 · The paper itself

Abstract

objectiveCompare all-cause mortality between Indigenous participants and participants of other ethnicities living with HIV initiating combination antiretroviral therapy (cART) in an interprovincial multi-site cohort.

methodsThe Canadian Observational Cohort is a collaboration of 8 cohorts of treatment-naïve persons with HIV initiating cART after January 1, 2000. Participants were followed from the cART initiation date until death or last viral load (VL) test date on or before December 31, 2012. Cox proportional hazard models were used to estimate the effect of ethnicity on time until death after adjusting for age, gender, injection drug use, being a man who has sex with men, hepatitis C, province of origin, baseline VL and CD4 count, year of cART initiation and class of antiretroviral medication.

resultsThe study sample consisted of 7080 participants (497 Indigenous, 2471 Caucasian, 787 African/Caribbean/Black (ACB), 629 other, and 2696 unknown ethnicity). Most Indigenous persons were from British Columbia (BC) (83%), with smaller numbers from Ontario (13%) and Québec (4%). During the study period, 714 (10%) participants died. The five-year survival probability was lower for Indigenous persons (0.77) than for Caucasian (0.94), ACB (0.98), other ethnicities (0.96) and unknown ethnicities (0.85) (p < 0.0001). In an adjusted proportional hazard model for which missing data were imputed, Indigenous persons were more likely to die than Caucasian participants (hazard ratio = 2.69, p < 0.0001).

conclusionThe mortality rate for Indigenous persons was higher than for other ethnicities and is largely reflective of the BC population. Addressing treatment challenges and identifying HIV- and non-HIV-related causes for mortality among Indigenous persons is required to optimize their clinical management.

Indexed as

Health Status DisparitiesAdultAnti-HIV AgentsCanadaCause of DeathCohort StudiesDrug Therapy, CombinationFemaleHIV InfectionsHumansIndians, North AmericanInuitMaleMiddle AgedMortalityAnti-HIV Agents

Identifiers

PMID28621653
PMCPMC6972082
OpenAlexW2626624331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.